IL6 and systemic-onset juvenile idiopathic arthritis: This study evaluated the effect of IL-1 or IL-6 inhibitor biologic use on subsequent glucocorticoid initiation in 468 hospitalized children with new-onset sJIA across 52 geographically diverse US children’s hospitals.